According to OpGen 's latest financial reports the company's current earnings (TTM) are -$26.17 M. In 2022 the company made an earning of -$37.29 M a decrease over its 2021 earnings that were of -$34.77 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$26.17 M | -29.83% |
2022 | -$37.29 M | 7.25% |
2021 | -$34.77 M | 33.3% |
2020 | -$26.08 M | 109.52% |
2019 | -$12.45 M | -6.89% |
2018 | -$13.37 M | -13.3% |
2017 | -$15.42 M | -19.55% |
2016 | -$19.17 M | 9.64% |
2015 | -$17.49 M | 208.23% |
2014 | -$5.68 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Lexicon Pharmaceuticals
LXRX | -$0.18 B | 577.01% | ๐บ๐ธ USA |
Enzo Biochem ENZ | -$9.61 M | -63.29% | ๐บ๐ธ USA |